These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 20410833

  • 21. MicroRNA-145 targeted therapy reduces atherosclerosis.
    Lovren F, Pan Y, Quan A, Singh KK, Shukla PC, Gupta N, Steer BM, Ingram AJ, Gupta M, Al-Omran M, Teoh H, Marsden PA, Verma S.
    Circulation; 2012 Sep 11; 126(11 Suppl 1):S81-90. PubMed ID: 22965997
    [Abstract] [Full Text] [Related]

  • 22. Lack of urokinase plasminogen activator promotes progression and instability of atherosclerotic lesions in apolipoprotein E-knockout mice.
    Dellas C, Schremmer C, Hasenfuss G, Konstantinides SV, Schäfer K.
    Thromb Haemost; 2007 Jul 11; 98(1):220-7. PubMed ID: 17598016
    [Abstract] [Full Text] [Related]

  • 23. Angiotensin inhibition decreases progression of advanced atherosclerosis and stabilizes established atherosclerotic plaques.
    Suganuma E, Babaev VR, Motojima M, Zuo Y, Ayabe N, Fogo AB, Ichikawa I, Linton MF, Fazio S, Kon V.
    J Am Soc Nephrol; 2007 Aug 11; 18(8):2311-9. PubMed ID: 17634441
    [Abstract] [Full Text] [Related]

  • 24. Smooth muscle cells healing atherosclerotic plaque disruptions are of local, not blood, origin in apolipoprotein E knockout mice.
    Bentzon JF, Sondergaard CS, Kassem M, Falk E.
    Circulation; 2007 Oct 30; 116(18):2053-61. PubMed ID: 17938286
    [Abstract] [Full Text] [Related]

  • 25. Transglutaminase 2 deficiency decreases plaque fibrosis and increases plaque inflammation in apolipoprotein-E-deficient mice.
    Van Herck JL, Schrijvers DM, De Meyer GR, Martinet W, Van Hove CE, Bult H, Vrints CJ, Herman AG.
    J Vasc Res; 2010 Oct 30; 47(3):231-40. PubMed ID: 19893320
    [Abstract] [Full Text] [Related]

  • 26. Detection of vulnerable plaque in a murine model of atherosclerosis with optical coherence tomography.
    Cilingiroglu M, Oh JH, Sugunan B, Kemp NJ, Kim J, Lee S, Zaatari HN, Escobedo D, Thomsen S, Milner TE, Feldman MD.
    Catheter Cardiovasc Interv; 2006 Jun 30; 67(6):915-23. PubMed ID: 16602128
    [Abstract] [Full Text] [Related]

  • 27. Nicotinic acid has anti-atherogenic and anti-inflammatory properties on advanced atherosclerotic lesions independent of its lipid-modifying capabilities.
    Holzhäuser E, Albrecht C, Zhou Q, Buttler A, Preusch MR, Blessing E, Katus HA, Bea F.
    J Cardiovasc Pharmacol; 2011 Apr 30; 57(4):447-54. PubMed ID: 21242806
    [Abstract] [Full Text] [Related]

  • 28. Potential role for mitogen-activated protein kinase phosphatase-1 in the development of atherosclerotic lesions in mouse models.
    Reddy ST, Nguyen JT, Grijalva V, Hough G, Hama S, Navab M, Fogelman AM.
    Arterioscler Thromb Vasc Biol; 2004 Sep 30; 24(9):1676-81. PubMed ID: 15242861
    [Abstract] [Full Text] [Related]

  • 29. Selective cathepsin S inhibition attenuates atherosclerosis in apolipoprotein E-deficient mice with chronic renal disease.
    Figueiredo JL, Aikawa M, Zheng C, Aaron J, Lax L, Libby P, de Lima Filho JL, Gruener S, Fingerle J, Haap W, Hartmann G, Aikawa E.
    Am J Pathol; 2015 Apr 30; 185(4):1156-66. PubMed ID: 25680278
    [Abstract] [Full Text] [Related]

  • 30. Gene profiling in atherosclerosis reveals a key role for small inducible cytokines: validation using a novel monocyte chemoattractant protein monoclonal antibody.
    Lutgens E, Faber B, Schapira K, Evelo CT, van Haaften R, Heeneman S, Cleutjens KB, Bijnens AP, Beckers L, Porter JG, Mackay CR, Rennert P, Bailly V, Jarpe M, Dolinski B, Koteliansky V, de Fougerolles T, Daemen MJ.
    Circulation; 2005 Jun 28; 111(25):3443-52. PubMed ID: 15967845
    [Abstract] [Full Text] [Related]

  • 31. Leucocyte cathepsin K affects atherosclerotic lesion composition and bone mineral density in low-density lipoprotein receptor deficient mice.
    Guo J, Bot I, de Nooijer R, Hoffman SJ, Stroup GB, Biessen EA, Benson GM, Groot PH, Van Eck M, Van Berkel TJ.
    Cardiovasc Res; 2009 Feb 01; 81(2):278-85. PubMed ID: 19015136
    [Abstract] [Full Text] [Related]

  • 32. Long-term administration of 3-deazaadenosine does not alter progression of advanced atherosclerotic lesions in apolipoprotein E-deficient mice.
    Preusch MR, Bea F, Yang SH, Kreuzer J, Isermann B, Pedal I, Rosenfeld ME, Katus HA, Blessing E.
    J Cardiovasc Pharmacol; 2007 Aug 01; 50(2):206-12. PubMed ID: 17703138
    [Abstract] [Full Text] [Related]

  • 33. The long-term effect of angiotensin II type 1a receptor deficiency on hypercholesterolemia-induced atherosclerosis.
    Eto H, Miyata M, Shirasawa T, Akasaki Y, Hamada N, Nagaki A, Orihara K, Biro S, Tei C.
    Hypertens Res; 2008 Aug 01; 31(8):1631-42. PubMed ID: 18971539
    [Abstract] [Full Text] [Related]

  • 34. Genetic loss of Gas6 induces plaque stability in experimental atherosclerosis.
    Lutgens E, Tjwa M, Garcia de Frutos P, Wijnands E, Beckers L, Dahlbäck B, Daemen MJ, Carmeliet P, Moons L.
    J Pathol; 2008 Sep 01; 216(1):55-63. PubMed ID: 18570189
    [Abstract] [Full Text] [Related]

  • 35. Cystatin C deficiency increases elastic lamina degradation and aortic dilatation in apolipoprotein E-null mice.
    Sukhova GK, Wang B, Libby P, Pan JH, Zhang Y, Grubb A, Fang K, Chapman HA, Shi GP.
    Circ Res; 2005 Feb 18; 96(3):368-75. PubMed ID: 15653570
    [Abstract] [Full Text] [Related]

  • 36. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice.
    Sukhanov S, Higashi Y, Shai SY, Vaughn C, Mohler J, Li Y, Song YH, Titterington J, Delafontaine P.
    Arterioscler Thromb Vasc Biol; 2007 Dec 18; 27(12):2684-90. PubMed ID: 17916769
    [Abstract] [Full Text] [Related]

  • 37. Matrix metalloproteinase-13/collagenase-3 deletion promotes collagen accumulation and organization in mouse atherosclerotic plaques.
    Deguchi JO, Aikawa E, Libby P, Vachon JR, Inada M, Krane SM, Whittaker P, Aikawa M.
    Circulation; 2005 Oct 25; 112(17):2708-15. PubMed ID: 16230484
    [Abstract] [Full Text] [Related]

  • 38. Lysosomal cysteine proteases in atherosclerosis.
    Liu J, Sukhova GK, Sun JS, Xu WH, Libby P, Shi GP.
    Arterioscler Thromb Vasc Biol; 2004 Aug 25; 24(8):1359-66. PubMed ID: 15178558
    [Abstract] [Full Text] [Related]

  • 39. Genetic deletion or antibody blockade of alpha1beta1 integrin induces a stable plaque phenotype in ApoE-/- mice.
    Schapira K, Lutgens E, de Fougerolles A, Sprague A, Roemen A, Gardner H, Koteliansky V, Daemen M, Heeneman S.
    Arterioscler Thromb Vasc Biol; 2005 Sep 25; 25(9):1917-24. PubMed ID: 15976328
    [Abstract] [Full Text] [Related]

  • 40. Melagatran reduces advanced atherosclerotic lesion size and may promote plaque stability in apolipoprotein E-deficient mice.
    Bea F, Kreuzer J, Preusch M, Schaab S, Isermann B, Rosenfeld ME, Katus H, Blessing E.
    Arterioscler Thromb Vasc Biol; 2006 Dec 25; 26(12):2787-92. PubMed ID: 16990551
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.